Epigallocatechin-3-Gallate Induces Cellular Differentiation and Reduces Leukemia Burden in PML/Rarα Mice By Increasing Reactive Oxygen Species and Reducing PIN1 Expression

白细胞增多症 细胞凋亡 白血病 血管生成 贫血 没食子酸表没食子酸酯 免疫学 癌症研究 内科学 生物 医学 化学 男科 生物化学 抗氧化剂 多酚
作者
Fernanda Isabel Della Via,Rodrigo Naoto Shiraishi,Santos Irene,Karla Priscila Ferro,Myriam Salazar-Terreros,Gilberto C. Franchi,Eduardo Magalhães Rego,Sara T.O. Saad,Cristiane Okuda Torello
出处
期刊:Blood [Elsevier BV]
卷期号:134 (Supplement_1): 5765-5765 被引量:2
标识
DOI:10.1182/blood-2019-130542
摘要

Background: (-)-Epigallocatechin-3-gallate (EGCG) is a gallate ester obtained by the condensation of gallic acid with the (3R)-hydroxy group of (-)-epigallocatechin. This component, extracted from green tea, has multiple effects on signal transduction pathways and enzyme activities which could enhance apoptosis and suppress of cell proliferation, invasion, angiogenesis and metastasis in cancers. This study aims to evaluate the effect of EGCG in an experimental model of leukemia (PML-RARα mice). Methods: NOD.CB17-Prkdcscid/J mice (12-16 weeks old) received 2Gy irradiation followed by transplantation of leukemia cells obtained from hCG-PML-RARα transgenic mice by i.v. injection in the caudal vein. Establishment of disease was confirmed at day 12 through presence of leukocytosis (>30x103/µL), and/or anemia (<10g/dL), and/or thrombocytopenia (<500x103/µL), associated to the presence of blasts in blood. At 12th day, mice (n=10/group) were randomly selected to receive EGCG (25mg/kg/day) (Cayman Chemical Co., Michigan, USA) or vehicle i.p. for five consecutive days. Mice were then sacrificed and peripheral blood, bone marrow and spleens were collected for flow cytometry and western blot analysis. All experiments were approved by the Ethical Committee for Animal Experimentation of Institution (nº3995-1/A). Results: Hematological analysis revealed that EGCG treatment reversed leukocytosis (54.09±57.71 vs 11.45±16.08; p=0.0371), anemia (9.60±1.50 vs 11.32±1.36; p=0.0155) and thrombocytopenia (238.5±146.43 vs 475.8±247.91; p=0.0179) and prolonged survival of PML/RARα mice (13 vs 15 days; p=0.0017). Notably, EGCG reduced leukemia immature cells (CD45+CD34+) (8.04±2.49 vs 5.13±1.58; p=0.0060) and promyelocytes (CD45+CD117+) (73.54±12.85 vs 56.26±15.93; p=0.0157) in bone marrow of mice whereas increased mature myeloid cells (CD11b+Gr-1+) (6.15±3.00 vs 14.60±7.83; p=0.0051), possibly by inducing cellular differentiation. These results were corroborated by the reduction in promyelocytes (45.97±11.72 vs 30.29±11.01; p=0.0154), and the increase in neutrophils (CD45+Gr-1+) (38.20±14.34 vs 54.88±14.25; p=0.0178) and monocytes (CD45+CD11b+) (60.22±18.87 vs 76.79±15.59; p=0.0463) detected in peripheral blood. We then evaluated the effect of EGCG on cellular differentiation by studying degradation of PML/RARα oncoprotein. EGCG increased the percentage of cells with aggregated PML bodies stain in the bone marrow of PML-RARα mice, suggestive of higher degradation of oncoprotein, parallel to a reduction in PIN1 expression in bone marrow cells. Higher intracellular levels of reactive oxygen species (ROS) were also detected in leukemia immature cells (2101±1025 vs 3544±614; p=0.0051), promyelocytes (1765±1176 vs 3090±1282; p=0.0271) and neutrophils (1830±1093 vs 3532±1157; p=0.0033) of bone marrow. These results are consistent with literature data demonstrating that the ablation of PIN1 and/or induction of ROS could trigger PML/RARα degradation. EGCG has been reported to inhibit PIN1, a peptidyl isomerase overexpressed and/or over activated in human cancers, which is described as a key target in PML/RARα. Furthermore, apoptosis was detected in spleen cells of PML-RARα mice (5.97±4.19 vs 10.42±3.54; p=0.0197) in parallel to increased expression of BAX, reduced expression of BCL-2, and reduction of spleen weight (0.5587±0.05 vs 0.3949±0.10; p=0.0085). Conclusion: Collectively, our results support further evaluation of EGCG in clinical trials for acute myeloid leukemia. Disclosures No relevant conflicts of interest to declare.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Kiki发布了新的文献求助10
2秒前
Cookie完成签到,获得积分10
3秒前
吃黄花菜发布了新的文献求助20
4秒前
4秒前
脑洞疼的应助被海哥哥采纳,获得10
6秒前
NexusExplorer的应助被pokexuejiao采纳,获得30
6秒前
6秒前
爆米花的应助被人有空call咪采纳,获得10
6秒前
6秒前
李健的小迷弟的应助被xiaoxuey采纳,获得10
6秒前
充电宝的应助被liuzhanyu采纳,获得30
7秒前
Fiszh完成签到,获得积分10
7秒前
CipherSage的应助被bestow采纳,获得10
7秒前
SciGPT的应助被xxx采纳,获得10
8秒前
8秒前
8秒前
秋风的应助被lhylhylhy采纳,获得10
8秒前
8秒前
王王完成签到 ,获得积分10
9秒前
9秒前
Fiszh发布了新的文献求助20
10秒前
11秒前
cdercder的应助被jiacooo采纳,获得10
11秒前
cuury5210发布了新的文献求助10
11秒前
planb发布了新的文献求助10
12秒前
深情安青的应助被Catea采纳,获得10
13秒前
hhpp发布了新的文献求助10
13秒前
苗英发布了新的文献求助10
13秒前
JJBOND发布了新的文献求助10
14秒前
14秒前
自觉千凝发布了新的文献求助10
14秒前
优雅的松鼠完成签到 ,获得积分20
14秒前
深情安青的应助被nini采纳,获得10
15秒前
tjr发布了新的文献求助10
15秒前
16秒前
黄雅静完成签到,获得积分10
17秒前
JJBOND完成签到,获得积分10
18秒前
18秒前
兔子胡萝卜完成签到,获得积分10
19秒前
dimension完成签到,获得积分10
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184267
求助须知:如何正确求助?哪些是违规求助? 9573323
关于积分的说明 21830790
捐赠科研通 7781314
什么是DOI,文献DOI怎么找? 3434307
关于科研通互助平台的介绍 2558389
邀请新用户注册赠送积分活动 2480817